CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled / 36 target
Drug / intervention
NEUROMARK Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05324397
NCT05324397N/ACompletedMonitor (0.7/mo)Completion was 32mo ago
CompareCT.gov

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis - A Prospective, Single-arm, Multicenter Clinical Study

Neurent Medical·interventional·Posted Apr 12, 2022·Updated Jun 8, 2026

In Brief

A clinical study evaluating NEUROMARK System for Chronic Rhinitis. Completed, enrolled 36 participants across 4 sites.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Rhinitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 12, 2022
Enrollment StartMar 14, 2022
Primary CompletionOct 4, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.2 years ago

Arms & Interventions

Experimental: Treatmentexperimental

Subjects will undergo treatment with the NEUROMARK System

Device: NEUROMARK System

Interventions

NEUROMARK Systemdevice

The NEUROMARK™ System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.